Moderator: ofonorow
RESULTS: Overall, reported flu and cold symptoms in the test group decreased 85% compared with the control group after the administration of megadose Vitamin C. CONCLUSION: Vitamin C in megadoses administered before or after the appearance of cold and flu symptoms relieved and prevented the symptoms in the test population compared with the control group.
In a message dated 10/15/2009 2:14:40 P.M. Central Daylight Time, Anitra.BrownReed@fda.hhs.gov writes:
Yesterday, a warning letter to Procter & Gamble regarding Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C products was posted to the FDA Web site in error. The posting occurred due to an internal systems error, and no warning letter has been sent to Procter & Gamble. The agency regrets any confusion caused by the posting.
Dear Anitra Brown,
Thank you for this response. However, I am interested in why the letter was written in the first place, and how it was instigated and by whom. Can you provide me with this information, or would I have to file a Freedom of Information Act request?
According to the massive research we are aware of, Vitamin C levels are depleted during illness and this is at least one reason why over-the-counter cold medicines for children are so dangerous. It is in the public interest for companies to add vitamin C to their cold medications.
Owen Fonorow
The Vitamin C Foundation
vitaminCFoundation.org
Yesterday, a warning letter to Procter & Gamble regarding Vicks DayQuil
Plus Vitamin C and Vicks Nyquil Plus Vitamin C products was posted to
the FDA Web site in error. The posting occurred due to an internal
systems error, and no warning letter has been sent to Procter & Gamble.
The agency regrets any confusion caused by the posting.
Anitra
Public Affairs Specialist;
CER\Philadelphia District
215-717-3004
anitra.brownreed@fda.hhs.gov
If God brings You to it, He will bring You through it!
Yesterday, a warning letter to Procter & Gamble regarding Vicks DayQuil
Plus Vitamin C and Vicks Nyquil Plus Vitamin C products was posted to
the FDA Web site in error. The posting occurred due to an internal
systems error, and no warning letter has been sent to Procter & Gamble.
The agency regrets any confusion caused by the posting.
Sincerely,
Stephen King
FDA Public Affairs Specialist
Baltimore District Office
Thanks for contacting Vicks NyQuil, Owen.
We appreciate the time you took to share this article with us, and I've shared it with the appropriate individuals on our team. For more than 30 years, NyQuil has provided safe and effective medicines to reduce the symptoms of cold and flu. Research has shown that levels of Vitamin C are depleted during times of illness. Vicks NyQuil Plus Vitamin C contains the combination of active ingredients to relieve cold and flu symptoms, and Vitamin C to replenish the body.
Thanks again for getting in touch.
Karen
Vicks NyQuil Team
It’s been suggested that you contact the FOI department and obtain that information through them.
FOI contact information:
If you wish to visit an FDA Public Reading Room in person, they are located at:
Division of Freedom of Information, 5600 Fishers Lane, HFI-35, Room 6-30, Rockville, MD 20857
Division of Dockets Management, 5630 Fishers Lane, Room 1061, Mail Stop HFA-305, Rockville, MD 20852.
Hours of operation for both sites are 9 a.m. to 4 p.m., Monday through Friday.
~or~
All FOIA requests made in writing should include the following information:
A. Requestor's name, address, and telephone number.
B. A description of the records being sought. The records should be identified as specifically as possible. A request for specific records that are releasable to the public can be processed much more quickly than a request for "all information" on a particular subject. Also fees for a more specific and limited request will generally be less.
C. Separate requests should be submitted for each firm or product involved.
D. A statement concerning willingness to pay fees, including any limitations.
Questions relating to FOI requests may be addressed to the Division of the Freedom of Information Offices at 301-827-6567.
All FOIA requests must be in writing. At this time, FDA does not accept FOIA requests sent via e-mail. Requests should be mailed to the following address:
Food and Drug Administration
Division of Freedom of Information (HFI-35)
Office of Shared Services
Office of Public Information and Library Services
5600 Fishers Lane
Rockville, MD 20857
Or requests may be sent via fax to: fax number 301-443-1726 or 301-443-1719. If experience difficulty sending a fax, please call (301) 443-2414.
Anitra
Public Affairs Specialist;
CER\Philadelphia District
215-717-3004
anitra.brownreed@fda.hhs.gov
If God brings You to it, He will bring You through it!
Hello,
The press release noted below will show that the posting of the subject
warning letter was truly a mistake.
If After reading the press release, you still have issues you wish to
discuss, feel free to write back or call me here in the office.
Best Regards.
Susan Seefeld, Public Affairs
U.S. Food and Drug Administration
Minneapolis District Office
250 Marquette Ave. - Suite 600
Minneapolis, MN 55401
Phone: 612-758-7130
Susan.Seefeld@FDA.HHS.GOV
For Immediate Release: Oct. 15, 2009
Contact: Christopher Kelly, 301-796-4676, christopher.kelly@fda.hhs.gov
FDA: Procter & Gamble Warning Posted in Error
Yesterday, a warning letter to Procter & Gamble regarding Vicks DayQuil
Plus Vitamin C and Vicks Nyquil Plus Vitamin C products was posted to
the FDA Web site in error. The posting occurred due to an internal
systems error, and no warning letter has been sent to Procter & Gamble.
The agency regrets any confusion caused by the posting.
#
ofonorow wrote:[color=#000080]Your perspective is different than mine. In my world, P&G is a consumer products company that may have medical/pharmaceutical products.
But you avoided commenting on the fact that someone in the FDA even wrote the letter in the first place!
Users browsing this forum: No registered users and 30 guests